| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/09/2010 | US7658825 Measuring device and measuring method for detecting analytes |
| 02/09/2010 | US7658823 Interdigitated electrochemical gas generator |
| 02/09/2010 | CA2536691C Methods for determing velocity of a stress wave within a material and homogeneity of properties within the material |
| 02/09/2010 | CA2532079C Remote monitoring system for water supply network |
| 02/09/2010 | CA2513579C Immunoassay and method of use |
| 02/09/2010 | CA2453110C System for the separation of magnetically attractable particles |
| 02/09/2010 | CA2451962C Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 02/09/2010 | CA2430217C Method for preventing chemical crosstalk in enzyme-linked reactions, and associated arrangement |
| 02/09/2010 | CA2408731C Device for sequential observation of samples and methods using same |
| 02/09/2010 | CA2401100C Analyzing and sorting of wood veneers |
| 02/09/2010 | CA2392033C Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 02/09/2010 | CA2387503C Fluorescent cobalamins and uses thereof |
| 02/09/2010 | CA2372666C Methods for predicting pregnancy outcome in a subject by hcg assay |
| 02/09/2010 | CA2353612C Boron neutron capture therapy using pre-targeting methods |
| 02/09/2010 | CA2349875C Dna encoding a growth factor specific for epithelial cells |
| 02/09/2010 | CA2341011C Induced aggregation and agglutination of platelets |
| 02/09/2010 | CA2328416C Antibody and use thereof |
| 02/09/2010 | CA2308274C Methods for modulating macrophage proliferation using polyamine analogs |
| 02/09/2010 | CA2300096C Methods and compositions for generating chemiluminescence with peroxidase enzymes |
| 02/09/2010 | CA2287469C Interactive system for presenting and eliminating substances |
| 02/09/2010 | CA2250212C Device and method for multiple analyte detection |
| 02/04/2010 | WO2010014978A1 Determination of circulating 1alpha, 25 (oh) 2d3 by enzyme electrode |
| 02/04/2010 | WO2010014820A2 Particles for use in supported nucleic acid ligation and detection sequencing |
| 02/04/2010 | WO2010014792A2 Method and device for incremental wavelength variation to analyze tissue |
| 02/04/2010 | WO2010014723A1 Methods and composition related to acetylcholine receptor conjugates |
| 02/04/2010 | WO2010014651A1 Pharmacogenetic markers for susceptibility to drug-induced pancreatic toxicity |
| 02/04/2010 | WO2010014643A1 Irak-1 as regulator of diseases and disorders |
| 02/04/2010 | WO2010014622A2 In vitro model for modulating the blood brain barrier and methods of screening |
| 02/04/2010 | WO2010014505A1 Systems and methods for optical measurement of analyte concentration |
| 02/04/2010 | WO2010014349A1 Immunoassay for detection of neurotoxic amino acid associated with neurological disorders |
| 02/04/2010 | WO2010014330A2 Method and apparatus for determining the yield of at least one component |
| 02/04/2010 | WO2010014225A2 Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase |
| 02/04/2010 | WO2010014046A1 Peristaltic movement simulating stirring device for dissolution testing |
| 02/04/2010 | WO2010014033A1 Separation device |
| 02/04/2010 | WO2010013933A2 Analysis method for identifying substances that modulate the interaction between rna molecules and proteins |
| 02/04/2010 | WO2010013865A1 Composition for glucose sensing comprising of nanofibrous membrane and method for manufacturing non-enzymatic glucose biosensor using the same |
| 02/04/2010 | WO2010013842A1 Method for detecting chromosome deficiencies for congenital abnormality |
| 02/04/2010 | WO2010013808A1 Method for assaying in vivo component, data processing method for assaying in vivo component and apparatus and collection member for assaying in vivo component |
| 02/04/2010 | WO2010013702A1 Method for measurement of physiologically active substance derived from organism and measurement apparatus |
| 02/04/2010 | WO2010013678A1 Reagent for detecting abnormal cell in cervix of uterus, and method for detecting abnormal cell in cervix of uterus by using same |
| 02/04/2010 | WO2010013525A1 Method of assaying complex and kit to be used therefor |
| 02/04/2010 | WO2010013485A1 Melk epitope peptides and vaccines containing the same |
| 02/04/2010 | WO2010013264A1 Diode laser device for the non-invasive measurement of glycaemia |
| 02/04/2010 | WO2010013127A1 Benzimidazole-derived compounds used as markers in the case of neurodegenerative diseases |
| 02/04/2010 | WO2010013023A1 Device for measuring air quality |
| 02/04/2010 | WO2010012975A1 Flow-through apparatus for testing particle laden fluids and methods of making and using same |
| 02/04/2010 | WO2010012962A2 Method for detecting membrane protein internalization |
| 02/04/2010 | WO2010012949A1 Marker reagents with a pyridine ring with a diazomethyl function substituent methods for synthesis of said reagents and methods for detecting biological molecules |
| 02/04/2010 | WO2010012834A1 Method for the in vitro diagnosis of stroke |
| 02/04/2010 | WO2010012828A2 Glutaminyl cyclase as a diagnostic / prognostic indicator for neurodegenerative diseases |
| 02/04/2010 | WO2010012641A1 Device and method for the automatic detection of biological particles |
| 02/04/2010 | WO2010012616A1 Blood glutathione as a biomarker for screening asymptomatic patients at risk for heart failure |
| 02/04/2010 | WO2010012509A1 Method for the in vitro diagnosis of stroke |
| 02/04/2010 | WO2010012306A1 Healthy kidney biomarkers |
| 02/04/2010 | WO2010012158A1 Detection apparatus |
| 02/04/2010 | WO2010012106A1 Selective glycosidase inhibitors and uses thereof |
| 02/04/2010 | WO2009150533A3 Analysis of vi saccharides |
| 02/04/2010 | WO2009150181A3 H-fabp as a marker for myocardial hibernation |
| 02/04/2010 | WO2009146213A3 Single nucleotide polymorphisms (snp) and association with resistance to immune tolerance induction |
| 02/04/2010 | WO2009139887A3 Non-inflammatory gluten peptide analogues as biomarkers for celiac sprue |
| 02/04/2010 | WO2009137801A3 Inhibitory rnas that regulate hematopoietic cells |
| 02/04/2010 | WO2009132308A3 Methods of identifying agents that promote axonal development |
| 02/04/2010 | WO2009111595A9 Diagnosing and monitoring depression disorders based on multiple biomarker panels |
| 02/04/2010 | WO2009097174A9 Electrochemical biosensor |
| 02/04/2010 | WO2009016180A3 Peptide imaging agents |
| 02/04/2010 | WO2009012343A9 Arrays, substrates, devices, methods and systems for detecting target molecules |
| 02/04/2010 | WO2008081455A3 Detection of analytes |
| 02/04/2010 | WO2003063798A9 Compositions and methods for treatment of infectious and inflammatory diseases |
| 02/04/2010 | US20100031394 Human Blood Proteins Expressed in Monocot Seeds |
| 02/04/2010 | US20100031378 Novel gene disruptions, compositions and methods relating thereto |
| 02/04/2010 | US20100030543 Products and processes for modulating peptide-peptide binding domain interactions |
| 02/04/2010 | US20100030530 Method of searching for ligand |
| 02/04/2010 | US20100030488 Method of calculating the structure of an inhomogeneous sample |
| 02/04/2010 | US20100030485 Signal processing for continuous analyte sensor |
| 02/04/2010 | US20100030483 Assessment method to process a glucose concentration signal and devices thereof |
| 02/04/2010 | US20100030475 Smart data subsurface data repository system, method and computer program product |
| 02/04/2010 | US20100030042 Method and device for determining oxygen saturation of hemoglobin, for determining hematocrit of blood, and/or for detecting macular degeneration |
| 02/04/2010 | US20100029773 Systematic identification of new anti-prion drugs by high-throughput screening based on scanning for intensely fluorescent targets (sift) |
| 02/04/2010 | US20100029734 Methods for breast cancer screening and treatment |
| 02/04/2010 | US20100029692 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
| 02/04/2010 | US20100029676 T315a and f317i mutations of bcr-abl kinase domain |
| 02/04/2010 | US20100029510 siRNA targeting survivin |
| 02/04/2010 | US20100029508 Nanochannel arrays and their preparation and use for high throughput macromolecular analysis |
| 02/04/2010 | US20100029501 Method of identifying micro-rna targets |
| 02/04/2010 | US20100029497 Method for engineering immunoglobulins |
| 02/04/2010 | US20100029495 Mass labels |
| 02/04/2010 | US20100029187 Method and device for processing fish, poultry, or other meat products transported in multitude along a processing line |
| 02/04/2010 | US20100029017 Mono-chlorinated hydroxycoumarin conjugates |
| 02/04/2010 | US20100029016 Nano-Sized Optical Fluorescence Labels and Uses Thereof |
| 02/04/2010 | US20100029015 Method of coupling binding agents to a substrate surface |
| 02/04/2010 | US20100029014 Micromachined diagnostic device with controlled flow of fluid and reaction |
| 02/04/2010 | US20100029013 Methods for Detecting Asymmetric Dimethylarginine in a Biological Sample |
| 02/04/2010 | US20100029012 Method for identifying modulators of the NRF2-KEAP1-AREP pathway |
| 02/04/2010 | US20100029011 Analytical test cartridge; and, methods |
| 02/04/2010 | US20100029010 Diaminorhodamine Derivative |
| 02/04/2010 | US20100029009 Methods for Determining Dysregulation of Methylation of Brain Expressed Genes on the X Chromosome to Diagnose Autism Spectrum Disorders |
| 02/04/2010 | US20100029008 Polymerase-independent analysis of the sequence of polynucleotides |
| 02/04/2010 | US20100029007 Biomarker in Inflammatory Diseases |
| 02/04/2010 | US20100029006 Multiplexed diagnostic test for preterm labor |
| 02/04/2010 | US20100029005 Method of Quantifying Membrane Protein By Using Mass Spectrometer |